129 related articles for article (PubMed ID: 21235283)
21. Ex vivo and in situ approaches used to study intestinal absorption.
Luo Z; Liu Y; Zhao B; Tang M; Dong H; Zhang L; Lv B; Wei L
J Pharmacol Toxicol Methods; 2013; 68(2):208-216. PubMed ID: 23831587
[TBL] [Abstract][Full Text] [Related]
22. Estimating drug solubility in the gastrointestinal tract.
Dressman JB; Vertzoni M; Goumas K; Reppas C
Adv Drug Deliv Rev; 2007 Jul; 59(7):591-602. PubMed ID: 17599644
[TBL] [Abstract][Full Text] [Related]
23. Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique.
von Richter O; Greiner B; Fromm MF; Fraser R; Omari T; Barclay ML; Dent J; Somogyi AA; Eichelbaum M
Clin Pharmacol Ther; 2001 Sep; 70(3):217-27. PubMed ID: 11557909
[TBL] [Abstract][Full Text] [Related]
24. The utility of cyclodextrins for enhancing oral bioavailability.
Carrier RL; Miller LA; Ahmed I
J Control Release; 2007 Nov; 123(2):78-99. PubMed ID: 17888540
[TBL] [Abstract][Full Text] [Related]
25. Integrating drug permeability with dissolution profile to develop IVIVC.
Takano R; Kataoka M; Yamashita S
Biopharm Drug Dispos; 2012 Oct; 33(7):354-65. PubMed ID: 22581486
[TBL] [Abstract][Full Text] [Related]
26. Enhancing the intestinal absorption of molecules containing the polar guanidino functionality: a double-targeted prodrug approach.
Sun J; Dahan A; Amidon GL
J Med Chem; 2010 Jan; 53(2):624-32. PubMed ID: 19957998
[TBL] [Abstract][Full Text] [Related]
27. Gastrointestinal contents in fasted state and post-lipid ingestion: in vivo measurements and in vitro models for studying oral drug delivery.
Di Maio S; Carrier RL
J Control Release; 2011 Apr; 151(2):110-22. PubMed ID: 21134406
[TBL] [Abstract][Full Text] [Related]
28. [Recent advance in predicting oral bioavailability].
Ma GL; Cheng YY
Yao Xue Xue Bao; 2006 Oct; 41(10):917-20. PubMed ID: 17184106
[No Abstract] [Full Text] [Related]
29. In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives.
Buckley ST; Fischer SM; Fricker G; Brandl M
Eur J Pharm Sci; 2012 Feb; 45(3):235-50. PubMed ID: 22178532
[TBL] [Abstract][Full Text] [Related]
30. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
Harde H; Das M; Jain S
Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
[TBL] [Abstract][Full Text] [Related]
31. Modeling of intestinal drug absorption: roles of transporters and metabolic enzymes (for the Gillette Review Series).
Pang KS
Drug Metab Dispos; 2003 Dec; 31(12):1507-19. PubMed ID: 14625347
[No Abstract] [Full Text] [Related]
32. Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability.
Lau YY; Chen YH; Liu TT; Li C; Cui X; White RE; Cheng KC
Drug Metab Dispos; 2004 Sep; 32(9):937-42. PubMed ID: 15319334
[TBL] [Abstract][Full Text] [Related]
33. A timely reassessment of early prediction in the bioavailability of orally administered drugs.
Larsen T; Link A
Angew Chem Int Ed Engl; 2005 Jul; 44(29):4432-4. PubMed ID: 15984039
[No Abstract] [Full Text] [Related]
34. Intestinal targeting of drugs: rational design approaches and challenges.
Filipski KJ; Varma MV; El-Kattan AF; Ambler CM; Ruggeri RB; Goosen TC; Cameron KO
Curr Top Med Chem; 2013; 13(7):776-802. PubMed ID: 23578023
[TBL] [Abstract][Full Text] [Related]
35. Patches for improving gastrointestinal absorption: an overview.
Teutonico D; Ponchel G
Drug Discov Today; 2011 Nov; 16(21-22):991-7. PubMed ID: 21683153
[TBL] [Abstract][Full Text] [Related]
36. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
Vasconcelos T; Sarmento B; Costa P
Drug Discov Today; 2007 Dec; 12(23-24):1068-75. PubMed ID: 18061887
[TBL] [Abstract][Full Text] [Related]
37. Enhancing oral absorption in animals.
Crowley PJ; Martini LG
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):73-80. PubMed ID: 11727326
[TBL] [Abstract][Full Text] [Related]
38. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs.
Kawakami K
Adv Drug Deliv Rev; 2012 May; 64(6):480-95. PubMed ID: 22265844
[TBL] [Abstract][Full Text] [Related]
39. The effect of food on drug bioavailability.
Toothaker RD; Welling PG
Annu Rev Pharmacol Toxicol; 1980; 20():173-99. PubMed ID: 6992698
[TBL] [Abstract][Full Text] [Related]
40. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs.
Rozehnal V; Nakai D; Hoepner U; Fischer T; Kamiyama E; Takahashi M; Yasuda S; Mueller J
Eur J Pharm Sci; 2012 Aug; 46(5):367-73. PubMed ID: 22418036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
